In our recent publication [4], we found that one representative mTOR kinase inhibitor, PP242, effectively decreased FLIPS levels and synergistically enhanced TRAIL-induced apoptosis in cancer cells although it alone had a very weak apoptosis-inducing activity. The gene discussed is TNFSF10; the disease is cancer.